-2, the covid-19 virus, as well as ways to fight it. That has highlighted the value of combining biotechnology and diagnostics. These are both fields in which Roche excels.
Mr Schwan, whose background is in diagnostics, can barely contain his excitement. After a long conversation with, he came back for more a day later. As he explains, cancer is a panoply of diseases based on individual mutations. Diagnostics identifies genetic and other differences between patients, leading to the creation of more personalised treatments.
Roche, which has recently fallen behind Merck, an oncology rival, in immunotherapy treatments, has been eagerly waiting for this digital tide to turn. Two American acquisitions in 2018 could prove particularly fruitful. One is Foundation Medicine, a gene-sequencing company that can identify cancers fromin blood samples, instead of from tumour biopsies.
good
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ELLE Magazine (US) - 🏆 472. / 51 Read more »
Source: Variety - 🏆 108. / 63 Read more »
Source: NYMag - 🏆 111. / 63 Read more »
Source: POPSUGARFashion - 🏆 28. / 68 Read more »
Source: ELLE Magazine (US) - 🏆 472. / 51 Read more »